Insulin-like growth factor-I response is comparable following intravenous and subcutaneous administration of growth hormone

Thomas Kimbrough, Stanton Shernan, Thomas R. Ziegler, Marc Scheltinga, Douglas W. Wilmore

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Subcutaneous (sq) administration of recombinant human growth hormone (r-hgh) has an anabolic effect and increases systemic insulin-like growth factor (IGF-I) in surgical patients. IGF-I is a mediator of growth hormone (gh) anabolic effects. To determine the effect of intravenous (iv) administration of r-hgh on systemic IGF-I, 11 patients were given 14 1-week courses of daily 8-hr infusions of r-hgh (10 mg in 500 ml D5W). Serum gh and IGF-I levels were measured. To compare routes of administration, iv r-hgh patients were matched to comparable sq r-hgh patients and IGF-I responses were examined. Illness severity effect on IGF-I response to r-hgh was assessed by dividing 16 burn patients who received either iv or sq r-hgh into two groups on the basis of severity scores. Analysis of the data showed that IGF-I levels increased significantly after iv r-hgh, IGF-I response to iv r-hgh (1.14 ± 0.18 U/ml to 4.12 ± 0.65 U/ml) was not different from IGF-I response to sq r-hgh (1.04 ± 0.36 U/ml to 4.96 ± 1.09 U/ml). Increasing illness severity attenuated the IGF-I response in the more severely injured group (0.91 ± 17 U/ml to 2.40 ± 0.38 U/ml) relative to the less severely injured group (1.37 ± 0.22 U/ml to 5.53 ± 0.78 U/ml) despite a significant increase in IGF-I after gh in both groups. In summary, IGF-I increased significantly after iv r-hgh and the increases were similar to those seen after sq r-hgh in comparable patients. Increasing severity of illness attenuated the IGF-I response to r-hgh given either iv or sq in burn patients.

Original languageEnglish (US)
Pages (from-to)472-476
Number of pages5
JournalJournal of Surgical Research
Volume51
Issue number6
DOIs
StatePublished - 1991
Externally publishedYes

Fingerprint

Insulin-Like Growth Factor I
Intravenous Administration
Human Growth Hormone
Growth Hormone
Anabolic Agents

ASJC Scopus subject areas

  • Surgery

Cite this

Insulin-like growth factor-I response is comparable following intravenous and subcutaneous administration of growth hormone. / Kimbrough, Thomas; Shernan, Stanton; Ziegler, Thomas R.; Scheltinga, Marc; Wilmore, Douglas W.

In: Journal of Surgical Research, Vol. 51, No. 6, 1991, p. 472-476.

Research output: Contribution to journalArticle

Kimbrough, Thomas ; Shernan, Stanton ; Ziegler, Thomas R. ; Scheltinga, Marc ; Wilmore, Douglas W. / Insulin-like growth factor-I response is comparable following intravenous and subcutaneous administration of growth hormone. In: Journal of Surgical Research. 1991 ; Vol. 51, No. 6. pp. 472-476.
@article{edd2f3c370b9453eb01d9b0c86458c9e,
title = "Insulin-like growth factor-I response is comparable following intravenous and subcutaneous administration of growth hormone",
abstract = "Subcutaneous (sq) administration of recombinant human growth hormone (r-hgh) has an anabolic effect and increases systemic insulin-like growth factor (IGF-I) in surgical patients. IGF-I is a mediator of growth hormone (gh) anabolic effects. To determine the effect of intravenous (iv) administration of r-hgh on systemic IGF-I, 11 patients were given 14 1-week courses of daily 8-hr infusions of r-hgh (10 mg in 500 ml D5W). Serum gh and IGF-I levels were measured. To compare routes of administration, iv r-hgh patients were matched to comparable sq r-hgh patients and IGF-I responses were examined. Illness severity effect on IGF-I response to r-hgh was assessed by dividing 16 burn patients who received either iv or sq r-hgh into two groups on the basis of severity scores. Analysis of the data showed that IGF-I levels increased significantly after iv r-hgh, IGF-I response to iv r-hgh (1.14 ± 0.18 U/ml to 4.12 ± 0.65 U/ml) was not different from IGF-I response to sq r-hgh (1.04 ± 0.36 U/ml to 4.96 ± 1.09 U/ml). Increasing illness severity attenuated the IGF-I response in the more severely injured group (0.91 ± 17 U/ml to 2.40 ± 0.38 U/ml) relative to the less severely injured group (1.37 ± 0.22 U/ml to 5.53 ± 0.78 U/ml) despite a significant increase in IGF-I after gh in both groups. In summary, IGF-I increased significantly after iv r-hgh and the increases were similar to those seen after sq r-hgh in comparable patients. Increasing severity of illness attenuated the IGF-I response to r-hgh given either iv or sq in burn patients.",
author = "Thomas Kimbrough and Stanton Shernan and Ziegler, {Thomas R.} and Marc Scheltinga and Wilmore, {Douglas W.}",
year = "1991",
doi = "10.1016/0022-4804(91)90167-K",
language = "English (US)",
volume = "51",
pages = "472--476",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Insulin-like growth factor-I response is comparable following intravenous and subcutaneous administration of growth hormone

AU - Kimbrough, Thomas

AU - Shernan, Stanton

AU - Ziegler, Thomas R.

AU - Scheltinga, Marc

AU - Wilmore, Douglas W.

PY - 1991

Y1 - 1991

N2 - Subcutaneous (sq) administration of recombinant human growth hormone (r-hgh) has an anabolic effect and increases systemic insulin-like growth factor (IGF-I) in surgical patients. IGF-I is a mediator of growth hormone (gh) anabolic effects. To determine the effect of intravenous (iv) administration of r-hgh on systemic IGF-I, 11 patients were given 14 1-week courses of daily 8-hr infusions of r-hgh (10 mg in 500 ml D5W). Serum gh and IGF-I levels were measured. To compare routes of administration, iv r-hgh patients were matched to comparable sq r-hgh patients and IGF-I responses were examined. Illness severity effect on IGF-I response to r-hgh was assessed by dividing 16 burn patients who received either iv or sq r-hgh into two groups on the basis of severity scores. Analysis of the data showed that IGF-I levels increased significantly after iv r-hgh, IGF-I response to iv r-hgh (1.14 ± 0.18 U/ml to 4.12 ± 0.65 U/ml) was not different from IGF-I response to sq r-hgh (1.04 ± 0.36 U/ml to 4.96 ± 1.09 U/ml). Increasing illness severity attenuated the IGF-I response in the more severely injured group (0.91 ± 17 U/ml to 2.40 ± 0.38 U/ml) relative to the less severely injured group (1.37 ± 0.22 U/ml to 5.53 ± 0.78 U/ml) despite a significant increase in IGF-I after gh in both groups. In summary, IGF-I increased significantly after iv r-hgh and the increases were similar to those seen after sq r-hgh in comparable patients. Increasing severity of illness attenuated the IGF-I response to r-hgh given either iv or sq in burn patients.

AB - Subcutaneous (sq) administration of recombinant human growth hormone (r-hgh) has an anabolic effect and increases systemic insulin-like growth factor (IGF-I) in surgical patients. IGF-I is a mediator of growth hormone (gh) anabolic effects. To determine the effect of intravenous (iv) administration of r-hgh on systemic IGF-I, 11 patients were given 14 1-week courses of daily 8-hr infusions of r-hgh (10 mg in 500 ml D5W). Serum gh and IGF-I levels were measured. To compare routes of administration, iv r-hgh patients were matched to comparable sq r-hgh patients and IGF-I responses were examined. Illness severity effect on IGF-I response to r-hgh was assessed by dividing 16 burn patients who received either iv or sq r-hgh into two groups on the basis of severity scores. Analysis of the data showed that IGF-I levels increased significantly after iv r-hgh, IGF-I response to iv r-hgh (1.14 ± 0.18 U/ml to 4.12 ± 0.65 U/ml) was not different from IGF-I response to sq r-hgh (1.04 ± 0.36 U/ml to 4.96 ± 1.09 U/ml). Increasing illness severity attenuated the IGF-I response in the more severely injured group (0.91 ± 17 U/ml to 2.40 ± 0.38 U/ml) relative to the less severely injured group (1.37 ± 0.22 U/ml to 5.53 ± 0.78 U/ml) despite a significant increase in IGF-I after gh in both groups. In summary, IGF-I increased significantly after iv r-hgh and the increases were similar to those seen after sq r-hgh in comparable patients. Increasing severity of illness attenuated the IGF-I response to r-hgh given either iv or sq in burn patients.

UR - http://www.scopus.com/inward/record.url?scp=0026351265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026351265&partnerID=8YFLogxK

U2 - 10.1016/0022-4804(91)90167-K

DO - 10.1016/0022-4804(91)90167-K

M3 - Article

VL - 51

SP - 472

EP - 476

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 6

ER -